Safety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein
SDG goal 3 SDG 3
Made by NKCU,TaiwanNational Cheng Kung University, Taiwan
Contents in more details >>> Expert Opin Drug Saf . 2022 Feb;21(2):157-166.
Download the list of all citations in map

Sign In - Safety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein

Sign In


New User? Click to Register!

Forgot Your Password? Click to Reset It

*You may want to update some relavent information after login.

*Pls contact me if any questions: cyanogmexp@gmail.com